Fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with inflammatory bowel disease was safe and well tolerated and resulted in a high rate of C. difficile decolonization, according to a study published in Gastroenterology.

“Additionally, positioning FMT earlier in the treatment course for patients with IBD-CDI may improve FMT failure rates,” Jessica R. Allegretti, MD, MPH, of the Brigham and Women’s Hospital Crohn’s and Colitis Center, and colleagues wrote.

Researchers performed an open-label prospective, single-arm cohort study

Full Article: https://www.healio.com/news/gastroenterology/20200731/fmt-safe-well-tolerated-for-recurrent-cdi-in-ibd